Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2776)
All Articles published online
|
Sep 21, 2006 (publication date) through Dec 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Derbala M, Kaabi SA, Dweik NE, Pasic F, Butt M, Yakoob R, Al-Marri A, Amer A, Morad N, Bener A. Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage. World J Gastroenterol 2006; 12(35): 5692-5698 [PMID: 17007024 DOI: 10.3748/wjg.v12.i35.5692] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i35/5692.htm |
| Number | Citing Articles |
| 1 |
Ayman A. Abdo, Faisal M. Sanai. Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects. Annals of Saudi Medicine 2009; 29(1): 1 doi: 10.4103/0256-4947.51810
|
| 2 |
Gasim I Gasim, Abdelhaleem Bella, Ishag Adam. Schistosomiasis, hepatitis B and hepatitis C co-infection. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0251-2
|
| 3 |
David J. Riedel, Simone Taylor, Raulina Simango, Athanase Kiromera, Jackson Sebeza, Cyprien Baribwira, Emmanuel Musabeyezu. Hepatitis C treatment outcomes using interferon- and ribavirin-based therapy in Kigali, Rwanda: Table 1.. Transactions of The Royal Society of Tropical Medicine and Hygiene 2016; 110(8): 495 doi: 10.1093/trstmh/trw055
|
| 4 |
A. Elsharkawy, R. Fouad, W. El Akel, M. El Raziky, M. Hassany, G. Shiha, M. Said, I. Motawea, T. El Demerdash, S. Seif, A. Gaballah, Y. El Shazly, M. A. M. Makhlouf, I. Waked, A. O. Abdelaziz, A. Yosry, M. El Serafy, M. Thursz, W. Doss, G. Esmat. Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. Alimentary Pharmacology & Therapeutics 2017; 45(5): 681 doi: 10.1111/apt.13923
|
| 5 |
Rosario González-Casas, María Trapero-Marugán, Ricardo Moreno-Otero. Hepatitis crónica por virus de la hepatitis C genotipo 4. Medicina Clínica 2011; 137(1): 31 doi: 10.1016/j.medcli.2010.03.022
|
| 6 |
Hamad I. Al-Ashgar, Mohammed Q. Khan, Ahmed Helmy, Sahar Al-Thawadi, Mohammed N. Al-Ahdal, Nisreen Khalaf, Ahmed Al-Qahtani, Faisal M Sanai. Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4. European Journal of Gastroenterology & Hepatology 2013; 25(4): 404 doi: 10.1097/MEG.0b013e32835bc2cf
|
| 7 |
Bushra Ijaz, Waqar Ahmad, Fouzia T Javed, Sana Gull, Muhammad T Sarwar, Humera Kausar, Sultan Asad, Shah Jahan, Saba Khaliq, Imran Shahid, Aleena Sumrin, Sajida Hassan. Association of laboratory parameters with viral factors in patients with hepatitis C. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-361
|
| 8 |
Maissa El Raziky, Waleed Fouad Fathalah, Zeinab Zakaria, Hadeel Gamal Eldeen, Amr Abul-Fotouh, Ahmed Salama, Abubakr Awad, Gamal Esmat, Mahasen Mabrouk. Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques. Journal of Interferon & Cytokine Research 2016; 36(5): 338 doi: 10.1089/jir.2015.0141
|
| 9 |
Gamal El Din Esmat Gamil, Maissa El Said El Raziky, Rabab Maamoun Salama, Wafaa Ahmed El Akel, Waleed Fouad Fathalah, Dina Ismail Attia. Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4. Advances in Infectious Diseases 2013; 3(02): 78 doi: 10.4236/aid.2013.32012
|
| 10 |
Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote. Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors. Gastroenterology 2008; 134(6): 1699 doi: 10.1053/j.gastro.2008.02.069
|
| 11 |
Brittany E. Yee, Nghia H. Nguyen, Bing Zhang, Philip Vutien, Carrie R. Wong, Glen A. Lutchman, Mindie H. Nguyen. Meta-analysis. European Journal of Gastroenterology & Hepatology 2014; 26(11): 1189 doi: 10.1097/MEG.0000000000000147
|
| 12 |
Okba Haj-Ali Saflo, Jesús Miguel Hernández Guijo. Coste-eficacia del tratamiento de la hepatitis C crónica en España. Gastroenterología y Hepatología 2009; 32(7): 472 doi: 10.1016/j.gastrohep.2009.01.181
|
| 13 |
Vasilios Papastergiou, Stylianos Karatapanis. Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6. World Journal of Clinical Cases 2015; 3(3): 210-220 doi: 10.12998/wjcc.v3.i3.210
|
| 14 |
Hamad Al Ashgar, Ahmed Helmy, Mohamed Q. Khan, Khalid Al Kahtani, Mohammed Al Quaiz, Mohammed Rezeig, Ingvar Kagevi, Abdullah Alshehri, Abdullah Al Kalbani, Khalid Al Swat, Salim Dahab, Naser Elkum, Mohammed Al Fadda. Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4. Annals of Saudi Medicine 2009; 29(1): 4 doi: 10.4103/0256-4947.51816
|
| 15 |
Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. Cochrane Database of Systematic Reviews 2014; 2014(2) doi: 10.1002/14651858.CD005441.pub3
|
| 16 |
Waqar Ahmad, Bushra Ijaz, Sana Gull, Sultan Asad, Saba Khaliq, Shah Jahan, Muhammad T Sarwar, Humera Kausar, Aleena Sumrin, Imran Shahid, Sajida Hassan. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-53
|
| 17 |
H.M. Dabbous, M.S. Elmeteini, M.A. Sakr, I.F. Montasser, M. Bahaa, A. Abdelaal, M. Fathy, R. Refaie, M. Seyam, A. Abdelmonem, A. Mukhtar, N. Hegazy, M. Almoneiri. Optimizing Outcome of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplantation: Moving Forward by Looking Back. Transplantation Proceedings 2014; 46(3): 822 doi: 10.1016/j.transproceed.2013.11.152
|
| 18 |
Tahany Awad, Kristian Thorlund, Mahasen Mabrouk, Christian Gluud. Hepatitis C intervention research – Where are we now and where should we be heading?. Arab Journal of Gastroenterology 2009; 10(1): 4 doi: 10.1016/j.ajg.2009.03.005
|
| 19 |
Sanaa M. Kamal, Imad A. Nasser. Hepatitis C genotype 4. Hepatology 2008; 47(4): 1371 doi: 10.1002/hep.22127
|
| 20 |
Mohamed Elashri, Farag M. Farag, Nader El-Malky, Elsayed Abd Elmaksood, Mohammed Elarman. Serum level of interleukin-8 and interleukin-10 as predictors for response to interferon–ribavirin combined therapy. Egyptian Liver Journal 2016; 6(1): 7 doi: 10.1097/01.ELX.0000481902.94221.61
|
| 21 |
Mahmoud A. Khattab, Peter Ferenci, Stephanos J. Hadziyannis, Massimo Colombo, Michael P. Manns, Piero L. Almasio, Rafael Esteban, Ayman A. Abdo, Stephen A. Harrison, Nazir Ibrahim, Patrice Cacoub, Mohammed Eslam, Samuel S. Lee. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. Journal of Hepatology 2011; 54(6): 1250 doi: 10.1016/j.jhep.2010.11.016
|
| 22 |
|
| 23 |
Shirin Mirza, Amna Rehana Siddiqui, Saeed Hamid, Muhammad Umar, Shaheena Bashir. Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-71
|
| 24 |
Gamal Esmat, Mohamed El Kassas, Mohamed Hassany, Mohamed Gamil, Maissa El Raziky. Optimizing treatment for HCV genotype 4: PEG‐IFN alfa 2a vs. PEG‐IFN alfa 2b; the debate continues. Liver International 2014; 34(s1): 24 doi: 10.1111/liv.12397
|
| 25 |
M. F. Derbala, N. Z. El Dweik, S. R. Al Kaabi, A. D. Al‐Marri, F. Pasic, A. B. Bener, F. M. Shebl, A. M. Amer, M. T. Butt, R. Yakoob, A. John, M. Al Mohanadi, M. A. Al Khinji. Viral kinetic of HCV genotype‐4 during pegylated interferon alpha 2a: ribavirin therapy. Journal of Viral Hepatitis 2008; 15(8): 591 doi: 10.1111/j.1365-2893.2008.00988.x
|
| 26 |
Brittany E Yee, Nghia H Nguyen, Bing Zhang, Derek Lin, Philip Vutien, Carrie R Wong, Glen A Lutchman, Mindie H Nguyen. Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis. BMJ Open Gastroenterology 2015; 2(1): e000049 doi: 10.1136/bmjgast-2015-000049
|
| 27 |
Vasilios Papastergiou, Dimitrios Dimitroulopoulos, Lamprini Skorda, Philippos Lisgos, Ioannis Ketikoglou, Nikolaos Kostas, Stylianos Karatapanis. Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: Does ethnicity matter?. Journal of Medical Virology 2012; 84(8): 1217 doi: 10.1002/jmv.23324
|
| 28 |
Nabil Antaki, Antonio Craxi, Sanaa Kamal, Rami Moucari, Schalk Van der Merwe, Samir Haffar, Adrian Gadano, Nizar Zein, Ching Lung Lai, Jean-Michel Pawlotsky, E. Jenny Heathcote, Geoffrey Dusheiko, Patrick Marcellin. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver International 2010; 30(3): 342 doi: 10.1111/j.1478-3231.2009.02188.x
|
| 29 |
Abdulrahman A. Aljumah, Mohammad Hassan Murad. Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta‐analysis. Hepatology Research 2013; 43(12): 1255 doi: 10.1111/hepr.12084
|
| 30 |
Jarrod Bailey. An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 2. Alternative Replacement Methods. Alternatives to Laboratory Animals 2010; 38(6): 471 doi: 10.1177/026119291003800602
|
| 31 |
Waqar Ahmad, Bushra Ijaz, Fouzia T Javed, Humera Kausar, Muhammad T Sarwar, Sana Gull, Sultan Asad, Imran Shahid, Sajida Hassan. HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-293
|
| 32 |
Menka M. Sanghvi, Peter J. Hotez, Alan Fenwick. Neglected tropical diseases as a cause of chronic liver disease: the case of Schistosomiasis and Hepatitis C Co‐infections in Egypt. Liver International 2013; 33(2): 165 doi: 10.1111/liv.12052
|